HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,406,000 | +37.1% | 265,076 | +76.7% | 2.87% | +84.9% |
| Q2 2022 | $11,964,000 | -77.4% | 150,000 | -70.2% | 1.55% | -75.4% |
| Q1 2022 | $52,999,000 | +107.1% | 503,744 | +112.1% | 6.30% | +76.8% |
| Q4 2021 | $25,590,000 | -59.3% | 237,470 | -58.7% | 3.57% | -60.5% |
| Q3 2021 | $62,927,000 | +8.6% | 574,467 | -7.1% | 9.03% | +51.4% |
| Q2 2021 | $57,923,000 | +25.9% | 618,573 | +23.7% | 5.97% | +2.0% |
| Q1 2021 | $46,020,000 | -3.2% | 500,000 | -23.1% | 5.85% | -5.1% |
| Q4 2020 | $47,548,000 | +74.9% | 650,000 | +85.7% | 6.16% | +1.4% |
| Q3 2020 | $27,188,000 | +12.2% | 350,000 | -19.7% | 6.08% | -0.5% |
| Q2 2020 | $24,240,000 | +63.7% | 436,127 | -12.8% | 6.10% | +6.6% |
| Q1 2020 | $14,810,000 | -16.2% | 500,000 | +2.4% | 5.73% | +22.3% |
| Q4 2019 | $17,676,000 | – | 488,298 | – | 4.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |